Brain Tunnelgenix's temperature monitoring system gets FDA nod
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for Brain Tunnelgenix Technologies' Abreu BTT 700, a system for continuous temperature monitoring. It is intended for placement on the skin during surgical procedures, in the recovery room and intensive care unit, and for general patient monitoring. The device measures skin temperature in the region between the eye and the eyebrow, known as the brain temperature tunnel. This fat-free area of skin has the highest level of thermoconductivity in the body, which enables temperature to be accurately and continuously monitored through the skin without losing thermal energy, the Hamden, Connecticut firm claims. The system will be available in the US next month.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.